Phlow’s capital raise announcement came a day after Gov. Glenn Youngkin and British pharmaceutical firm AstraZeneca publicly ...

The new funding helps Phlow accelerate its mission to help make ingredients for medicines either considered in short supply ...

Richmond-based pharmaceutical manufacturing company Phlow announced Tuesday that it had secured $37 million in a capital raise.

The arrangement will allow medicines to be built inside the United States from start to finish, Phlow's CEO said.

Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), and Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine ...

Phlow’s Series C funding coincides with several significant milestones this year, including the two newly operational U.S.-based cGMP manufacturing facilities, capable of producing APIs at both ...

Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced the successful close of its Series C financing round at an increased ...

Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced the successful close of its Series C financing ...